Literature DB >> 18184700

Phagocytosis of picornavirus-infected cells induces an RNA-dependent antiviral state in human dendritic cells.

Matthijs Kramer1, Barbara M Schulte, Liza W J Toonen, Paola M Barral, Paul B Fisher, Kjerstin H W Lanke, Jochem M D Galama, Frank J M van Kuppeveld, Gosse J Adema.   

Abstract

Dendritic cells (DCs) play a central role in instructing antiviral immune responses. DCs, however, can become targeted by different viruses themselves. We recently demonstrated that human DCs can be productively infected with echoviruses (EVs), but not coxsackie B viruses (CVBs), both of which are RNA viruses belonging to the Enterovirus genus of the Picornaviridae family. We now show that phagocytosis of CVB-infected, type I interferon-deficient cells induces an antiviral state in human DCs. Uptake of infected cells increased the expression of the cytoplasmic RNA helicases retinoic acid-inducible gene I and melanoma differentiation-associated gene 5 as well as other interferon-stimulated genes and protected DCs against subsequent infection with EV9. These effects depended on recognition of viral RNA and could be mimicked by exposure to the synthetic double-stranded RNA analogue poly(I:C) but not other Toll-like receptor (TLR) ligands. Blocking endosomal acidification abrogated protection, suggesting a role for TLRs in the acquisition of an antiviral state in DCs. In conclusion, recognition of viral RNA rapidly induces an antiviral state in human DCs. This might provide a mechanism by which DCs protect themselves against viruses when attracted to an environment with ongoing infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184700      PMCID: PMC2258994          DOI: 10.1128/JVI.02376-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells.

Authors:  D Jarrossay; G Napolitani; M Colonna; F Sallusto; A Lanzavecchia
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

2.  Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

Authors:  M Cella; F Facchetti; A Lanzavecchia; M Colonna
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

3.  A PCR primer bank for quantitative gene expression analysis.

Authors:  Xiaowei Wang; Brian Seed
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

4.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.

Authors:  Dong-chul Kang; Rahul V Gopalkrishnan; Qingping Wu; Eckhard Jankowsky; Anna Marie Pyle; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus.

Authors:  Leonid Gitlin; Winfried Barchet; Susan Gilfillan; Marina Cella; Bruce Beutler; Richard A Flavell; Michael S Diamond; Marco Colonna
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-19       Impact factor: 11.205

6.  Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.

Authors:  Sandra S Diebold; Tsuneyasu Kaisho; Hiroaki Hemmi; Shizuo Akira; Caetano Reis e Sousa
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

7.  Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.

Authors:  Florian Heil; Hiroaki Hemmi; Hubertus Hochrein; Franziska Ampenberger; Carsten Kirschning; Shizuo Akira; Grayson Lipford; Hermann Wagner; Stefan Bauer
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

8.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

9.  Subcellular localization of Toll-like receptor 3 in human dendritic cells.

Authors:  Misako Matsumoto; Kenji Funami; Masako Tanabe; Hiroyuki Oshiumi; Masashi Shingai; Yoshiyuki Seto; Akitsugu Yamamoto; Tsukasa Seya
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

10.  Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.

Authors:  Sandra S Diebold; Maria Montoya; Hermann Unger; Lena Alexopoulou; Polly Roy; Linsey E Haswell; Aymen Al-Shamkhani; Richard Flavell; Persephone Borrow; Caetano Reis e Sousa
Journal:  Nature       Date:  2003-06-22       Impact factor: 49.962

View more
  13 in total

1.  The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice.

Authors:  Yuko Abe; Ken Fujii; Noriyo Nagata; Osamu Takeuchi; Shizuo Akira; Hiroyuki Oshiumi; Misako Matsumoto; Tsukasa Seya; Satoshi Koike
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  A novel population of myeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS.

Authors:  Jenna M Tabor-Godwin; Chelsea M Ruller; Nolan Bagalso; Naili An; Robb R Pagarigan; Stephanie Harkins; Paul E Gilbert; William B Kiosses; Natalie A Gude; Christopher T Cornell; Kelly S Doran; Mark A Sussman; J Lindsay Whitton; Ralph Feuer
Journal:  J Neurosci       Date:  2010-06-23       Impact factor: 6.167

Review 3.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

4.  Enterovirus infection of human beta-cells activates dendritic cells and triggers innate antiviral responses: are enteroviruses convicted now?

Authors:  Urs Christen
Journal:  Diabetes       Date:  2010-05       Impact factor: 9.461

5.  Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection.

Authors:  Kreso Bendelja; Valerija Vojvoda; Neda Aberle; Jasna Cepin-Bogovic; Alenka Gagro; Gordana Mlinaric-Galinovic; Sabina Rabatic
Journal:  Respir Res       Date:  2010-10-14

6.  Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein.

Authors:  Céline Ricour; Sophie Delhaye; Stanleyson V Hato; Tamara D Olenyik; Bénédicte Michel; Frank J M van Kuppeveld; Kurt E Gustin; Thomas Michiels
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

7.  Distinct activation of primary human BDCA1(+) dendritic cells upon interaction with stressed or infected β cells.

Authors:  B M Schulte; E D Kers-Rebel; R Bottino; J D Piganelli; J M D Galama; M A Engelse; E J P de Koning; G J Adema
Journal:  Clin Exp Immunol       Date:  2016-03-23       Impact factor: 4.330

8.  Cytokine and chemokine production by human pancreatic islets upon enterovirus infection.

Authors:  Barbara M Schulte; Kjerstin H W Lanke; Jon D Piganelli; Esther D Kers-Rebel; Rita Bottino; Massimo Trucco; Richard J F Huijbens; Timothy R D J Radstake; Marten A Engelse; Eelco J P de Koning; Jochem M Galama; Gosse J Adema; Frank J M van Kuppeveld
Journal:  Diabetes       Date:  2012-05-17       Impact factor: 9.461

9.  Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells.

Authors:  Barbara M Schulte; Matthijs Kramer; Marleen Ansems; Kjerstin H W Lanke; Neeltje van Doremalen; Jon D Piganelli; Rita Bottino; Massimo Trucco; Jochem M D Galama; Gosse J Adema; Frank J M van Kuppeveld
Journal:  Diabetes       Date:  2010-01-13       Impact factor: 9.461

10.  Differential susceptibility and response of primary human myeloid BDCA1(+) dendritic cells to infection with different Enteroviruses.

Authors:  Barbara M Schulte; Esther D Kers-Rebel; Amy C Prosser; Jochem M D Galama; Frank J M van Kuppeveld; Gosse J Adema
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.